Stock Price
77.48
Daily Change
-0.28 -0.36%
Monthly
4.00%
Yearly
-1.40%
Q2 Forecast
77.88

EPS Reference Time Actual Consensus Previous
2026-04-28 FY2026Q1 PM 2.09 2.04
2026-02-05 FY2025Q4 PM 1.92 2.12 2.03
2025-11-03 FY2025Q3 PM 2.09 2.18 2.13
2025-07-29 FY2025Q2 PM 2.07 2.24 2.16
2025-04-29 FY2025Q1 PM 2.04 2.20 2.12



Peers Price Chg Day Year Date
Atlantic American 2.57 0.01 0.39% 69.09% Apr/24
Arch Capital 96.19 -1.88 -1.92% 6.08% Apr/24
Aflac 114.62 -0.50 -0.43% 6.19% Apr/24
Aegon 6.87 -0.02 -0.35% 20.48% Apr/24
AIG 75.14 -1.19 -1.56% -7.49% Apr/24
Assurant 229.80 -0.66 -0.29% 20.42% Apr/24
Arthur J. Gallagher 215.38 -3.99 -1.82% -33.17% Apr/24
Allstate 212.88 -3.68 -1.70% 10.35% Apr/24
Ameriprise Financial 463.32 3.69 0.80% -0.56% Apr/24
AON 321.40 -2.67 -0.82% -4.48% Apr/24


Unum traded at $77.48 this Friday April 24th, decreasing $0.28 or 0.36 percent since the previous trading session. Looking back, over the last four weeks, Unum lost 4.00 percent. Over the last 12 months, its price fell by 1.40 percent. Looking ahead, we forecast Unum to be priced at 77.88 by the end of this quarter and at 72.85 in one year, according to Trading Economics global macro models projections and analysts expectations.

Unum Group is a provider of financial protection benefits in the United States and the United Kingdom. Its products include disability, life, accident, critical illness, dental and vision, and other related services. Its Unum US segment consists of group disability insurance, which includes long-term and short-term disability products, medical stop-loss product, and fee-based leave management services and administrative services only (ASO) business, group life and accidental death and dismemberment products, and supplemental and voluntary lines of business, which include individual disability, voluntary benefits, and dental and vision products. Its Unum International segment includes its operations in the United Kingdom and Poland. Its Colonial Life segment includes accident, sickness, and disability products, which includes its dental and vision products, life products, and cancer and critical illness products. It markets its products primarily through the workplace.